Bonum Therapeutics
PrivateLast Round
Early Stage
VC
Apr 17, 2026
Total Funding Raised
$93M
Momentum Score
50 /100
Company Overview
Bonum Therapeutics is a biopharmaceutical company focused on developing protein-based drugs that can sense their local environment and activate in response, aiming to provide targeted treatments for previously incurable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bonum Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Bonum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Apr 17, 2026 | ||||
| Series A | Nov 15, 2022 |
Bonum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Codon Capital | Series A |
| Digitalis Ventures | Series A |
| RiverVest Venture Partners | Series A |
| Roche Venture Fund | Series A |
| 3x5 Partners | Series A |
| Vivo Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Raised $27M in an early stage VC round.
Bonum Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bonum Therapeutics's valuation, stock price, and market status.
